OSE Immunotherapeutics SA
OSE Immunotherapeutics SA focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. Its products include Tedopi that is in Phase III clinical stage for the treatment of no…
Biotechnology
FR, Nantes [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
OSE Immunotherapeutics SA can't present it's latest revenue by geo. area
Revenue By Geographic Areas
OSE Immunotherapeutics SA can't present it's latest revenue by geo. area
Historical Revenue By Segment
Last 3Y, in mil. USDOSE Immunotherapeutics SA can't present revenue by segment
Historical Revenue By Geographic Area
Last 3Y, in mil. USDOSE Immunotherapeutics SA can't present revenue by geo. area